SVP, Development Operations
Peel Therapeutics
Debra Thoma Vallner, Ph.D., MBA is the Sr. VP of Development Operations at Peel. She has over thirty-five years of experience in drug development. Previously, Dr. Vallner has held senior leadership positions at Roche, Nektar, Exelixis, Anthera, Anacor, eFFECTOR and Eiger Biopharmaceuticals. She holds a Ph.D. in Pharmacology and Toxicology from West Virginia University School of Medicine and an MBA from Golden Gate University.